TNB
BIIB icon

TCF National Bank’s Biogen BIIB Stock Holding History

TCF National Bank’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$434K Sell
1,550
-25
-2% -$6.74K 0.05% 279
2020
Q4 		$386K Buy
1,575
+25
+2% +$6.45K 0.04% 286
2020
Q3 		$440K Hold
1,550
– – 0.05% 259
2020
Q2 		$362K Hold
1,550
– – 0.04% 284
2020
Q1 		$490K Hold
1,550
– – 0.07% 223
2019
Q4 		$460K Hold
1,550
– – 0.05% 257
2019
Q3 		$361K Buy
+1,550
New +$361K 0.04% 281

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TCF National Bank's BIIB Position: Q1 2021 in Review

TCF National Bank reduced its Biogen (BIIB) stake by 1.6% in Q1 2021, selling an estimated $6.74K and leaving 1,550 shares worth $434K. The position accounts for 0.05% of the portfolio, ranked #279.

TCF National Bank first reported a position in BIIB in Q3 2019 and has held it in 7 quarters since. The position peaked at $490K in Q1 2020. 1,093 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.

  • TCF National Bank held 1,550 shares of Biogen worth $434K as of Q1 2021.
  • TCF National Bank sold 25 Biogen shares in Q1 2021, an estimated $6.74K.
  • Biogen made up 0.05% of TCF National Bank's portfolio in Q1 2021, its #279 holding.
  • TCF National Bank first reported a position in Biogen in Q3 2019 and has held it in 7 quarters since.
  • TCF National Bank's Biogen position peaked at $490K in Q1 2020.
  • 1,093 funds tracked by Wall St. Rank held Biogen as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.